Xeris Biopharma Inc. (XERS)
NASDAQ: XERS
· Real-Time Price · USD
7.66
0.36 (4.93%)
At close: Aug 15, 2025, 3:59 PM
7.67
0.13%
After-hours: Aug 15, 2025, 07:25 PM EDT
Xeris Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 59.28M | 58.44M | 71.62M | 59.23M | 57.6M | 62.69M | 67.45M | 46.14M | 46.17M | 50.98M | 121.97M | 84.11M | 95.34M | 103.77M | 67.27M | 59.49M | 63.6M | 66.6M |
Short-Term Investments | n/a | n/a | n/a | 10.17M | 19.96M | 24.66M | 5M | 19.83M | 34.5M | 44.12M | n/a | 9.32M | 16.21M | 28.38M | 35.16M | 33.49M | 52.38M | 69.29M |
Long-Term Investments | n/a | n/a | n/a | n/a | 4.22M | 4.22M | 4.22M | n/a | n/a | 4.35M | n/a | n/a | n/a | n/a | -364K | n/a | n/a | n/a |
Other Long-Term Assets | 5.06M | 5.1M | 5.41M | 5.44M | 1.27M | 389K | 315K | 4.81M | 4.81M | 4.73M | 4.73M | 2.17M | 2.35M | 2.18M | 465K | 211K | 211K | 212K |
Receivables | 53.05M | 46.33M | 40.41M | 41.14M | 42.44M | 37.41M | 39.2M | 45.97M | 30.23M | 30.86M | 30.83M | 27.52M | 25.76M | 23.38M | 17.46M | 13.56M | 12.29M | 8.94M |
Inventory | 67.28M | 52.69M | 48.17M | 45.12M | 42.98M | 40.88M | 38.84M | 38.14M | 36.54M | 29.04M | 24.73M | 20.12M | 17.89M | 16.87M | 18.12M | 14.24M | 12.3M | 12.5M |
Other Current Assets | 5.96M | 6.03M | 7.45M | 7.14M | 7.36M | 7.64M | 5.78M | 7.97M | 8.31M | 10.51M | 9.29M | 7.85M | 6.01M | 5.15M | 4.59M | 3.58M | n/a | n/a |
Total Current Assets | 185.58M | 163.49M | 167.66M | 162.8M | 170.34M | 173.28M | 156.26M | 158.05M | 155.74M | 165.51M | 186.82M | 148.92M | 161.21M | 177.55M | 142.6M | 124.37M | 144.59M | 160.63M |
Property-Plant & Equipment | 27.69M | 27.79M | 28.21M | 28.37M | 28.7M | 28.81M | 29.18M | 29.59M | 30.18M | 10.36M | 9.51M | 5.75M | 6.17M | 6.29M | 6.63M | 6.68M | 6.7M | 6.8M |
Goodwill & Intangibles | 116.36M | 119.07M | 121.78M | 124.49M | 127.2M | 129.91M | 132.62M | 135.33M | 138.04M | 140.75M | 143.47M | 146.18M | 148.89M | 151.6M | 154.31M | n/a | n/a | n/a |
Total Long-Term Assets | 149.11M | 151.96M | 155.4M | 158.31M | 161.39M | 163.34M | 184.53M | 169.73M | 173.04M | 155.85M | 157.7M | 154.1M | 157.41M | 160.07M | 161.76M | 6.89M | 6.91M | 7.01M |
Total Assets | 334.69M | 315.45M | 323.06M | 321.1M | 331.73M | 336.62M | 340.8M | 327.78M | 328.78M | 321.36M | 344.52M | 303.02M | 318.62M | 337.62M | 304.36M | 131.26M | 151.5M | 167.64M |
Account Payables | 9.46M | 6.35M | 2.29M | 7.45M | 5.8M | 7.09M | 11.56M | 12.08M | 11.62M | 11.98M | 4.61M | 3.92M | 6.63M | 11.09M | 8.92M | 4.29M | 5.18M | 4.77M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 53.95M | 47.77M | 50.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 6.16M | 11.96M | 15.1M | 15.06M | 5.31M | n/a | 3.5M | 2.37M | 1.94M | 1.45M | n/a | n/a | n/a | 341K | n/a | n/a | n/a | n/a |
Other Current Liabilities | 79.55M | 32.38M | 39.75M | 34.83M | 46.25M | 16.41M | 59.68M | 41.33M | 38.71M | 38.28M | 27.23M | 18.19M | 17.63M | 19.38M | 18.95M | 5.93M | 6.47M | 3.54M |
Total Current Liabilities | 95.17M | 95.07M | 100.44M | 91.01M | 75.49M | 73.08M | 95.19M | 87.04M | 79.68M | 81.42M | 73.62M | 68.56M | 64.55M | 66.49M | 79.04M | 37.28M | 35.46M | 27.42M |
Long-Term Debt | 218.63M | 217.81M | 217.01M | 216.23M | 230.48M | 229.67M | 190.93M | 190.42M | 188.18M | 187.62M | 187.07M | 138.51M | 138.07M | 137.64M | 88.07M | 87.71M | 87.48M | 87.27M |
Other Long-Term Liabilities | 7.75M | 4.83M | 1.97M | 8.55M | 7.71M | 6.06M | 6.23M | 8.8M | 9.56M | 9.4M | 25.72M | 37.06M | 37.87M | 32.5M | 37.08M | 8.72M | 8.67M | 8.55M |
Total Long-Term Liabilities | 258.82M | 255.51M | 252.23M | 258.41M | 275.53M | 272.71M | 252.39M | 236.88M | 235.46M | 209.89M | 225.71M | 179.42M | 180.13M | 174.68M | 130.09M | 96.44M | 96.14M | 95.83M |
Total Liabilities | 353.99M | 350.58M | 352.68M | 349.43M | 351.02M | 345.79M | 347.58M | 323.92M | 315.14M | 291.31M | 299.33M | 247.98M | 244.67M | 241.17M | 209.13M | 133.72M | 131.61M | 123.25M |
Total Debt | 257.22M | 268.75M | 271.45M | 270.96M | 269.8M | 268.69M | 229.19M | 227.94M | 224.99M | 198.42M | 198.06M | 138.51M | 138.07M | 137.98M | 88.07M | 87.71M | 87.48M | 87.27M |
Common Stock | n/a | 16K | 15K | 15K | 15K | 15K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 13K | 7K | 7K | 7K |
Retained Earnings | n/a | -681.08M | -671.86M | -666.75M | -651.01M | -636M | -617.02M | -603.63M | -591.45M | -571.6M | -554.77M | -541.84M | -520.01M | -493.82M | -460.11M | -409.32M | -383.31M | -355.8M |
Comprehensive Income | n/a | -25K | -25K | -16K | -31K | -36K | -25K | -50K | -78K | -29K | -23K | -37K | -52K | -66K | -31K | -26K | -20K | -10K |
Shareholders Equity | -19.3M | -35.13M | -29.61M | -28.32M | -19.29M | -9.18M | -6.78M | 3.87M | 13.64M | 30.05M | 45.19M | 55.04M | 73.94M | 96.45M | 95.23M | -2.46M | 19.89M | 44.39M |
Total Investments | n/a | n/a | n/a | 10.17M | 24.19M | 28.89M | 9.23M | 19.83M | 34.5M | 44.12M | n/a | 9.32M | 16.21M | 28.38M | 35.16M | 33.49M | 52.38M | 69.29M |